Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

Conventional disease-modifying antirheumatic drugs such as methotrexate are the mainstay of treatment for rheumatoid arthritis. More recently, biologic agents such as etanercept, infliximab and adalimumab, which act by inhibiting tumour necrosis factor (TNF), have become available. TNF inhibitors ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubbert-Roth, Andrea, Finckh, Axel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669237/
https://www.ncbi.nlm.nih.gov/pubmed/19368701
http://dx.doi.org/10.1186/ar2666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669237/
https://www.ncbi.nlm.nih.gov/pubmed/19368701
http://dx.doi.org/10.1186/ar2666

Ejemplares similares